| 2025-05-05 | -0.57 % |
|
| 2025-05-02 | +1.49 % |
|
| 2025-04-23 | +0.52 % |
|
| 2025-04-22 | +2.18 % |
|
| 2025-04-21 | -0.85 % |
|
| 2025-04-15 | -1.11 % |
|
| 2025-04-09 | +4.78 % |
|
| 2025-04-07 | -0.18 % |
|
| 2025-03-31 | +0.66 % |
|
| 2025-03-20 | -2.71 % |
|
| 2025-03-19 | -0.04 % |
|
| 2025-03-13 | -0.55 % |
|
| 2025-03-12 | -0.38 % |
|
| 2025-03-11 | -2.38 % |
|
| 2025-03-07 | +4.64 % |
|
| 2025-03-04 | +2.34 % |
|
| 2025-02-28 | +0.23 % |
|
| 2025-02-27 | +0.06 % |
|
| 2025-02-19 | +0.18 % |
|
| 2025-02-18 | -0.75 % |
|
| 2025-02-14 | +1.23 % |
|
| 2025-02-13 | -4.53 % |
|
| 2025-02-11 | -3.62 % |
|
| 2025-02-10 | +0.35 % |
|
| 2025-02-06 | -0.33 % |
|
| 2025-02-05 | -0.47 % |
|
| 2025-01-31 | -0.11 % |
|
| 2025-01-23 | -7.57 % |
|
| 2025-01-22 | +0.33 % |
|
| 2025-01-16 | -0.1 % |
|
| 2025-01-14 | +0.08 % |
|
| 2025-01-13 | +2.14 % |
|
| 2025-01-10 | +2.53 % |
|
| 2025-01-08 | -1.05 % |
|
| 2025-01-07 | -0.63 % |
|
| 2025-01-06 | +0.74 % |
|
| 2024-12-20 | +1.12 % |
|
| 2024-12-19 | -1.95 % |
|
| 2024-12-17 | -1.55 % |
|
| 2024-12-10 | -0.09 % |
|
| 2024-12-04 | +0.57 % |
|
| 2024-12-03 | |
- The article discusses the challenges new CEOs face in establishing productive relationships with their boards of directors, which can lead to dysfunction and impact company performance, including stock prices. Leidos (LDOS) stock has remained flat, down 0.0%, potentially due to market reactions to such governance dynamics and the performance issues mentioned that can arise from ineffective board-CEO relationships.
- Leidos (LDOS) stock remained unchanged at 0.0% down as UBS Group initiated coverage with a neutral rating and a target price of $182.00, while various analysts adjusted their price targets, reflecting mixed sentiments about the stock’s future performance. The stock's decline may be influenced by the cautious approach taken by UBS and price target cuts from other firms, suggesting potential concerns about near-term growth.
- Leidos Holdings, Inc. (LDOS) shares remained flat with a 0.0% decline despite a consensus “Moderate Buy” rating from analysts, as the stock was impacted by recent price target adjustments from several financial institutions, reflecting a more cautious outlook amid market conditions.
|
| 2024-12-02 | -0.77 % |
|
| 2024-11-25 | -1.15 % |
|
| 2024-11-21 | +1.57 % |
|
| 2024-11-20 | +2.44 % |
|
| 2024-11-19 | -0.35 % |
|
| 2024-11-15 | -4.35 % |
|
| 2024-11-08 | +3.01 % |
|
| 2024-11-07 | -0.81 % |
|
